ArticleMaterials today. Bio2025
A multifunctional parathyroid hormone-related supramolecular peptide-loaded dual network hydrogel for radiation-induced wound repair.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hydrogels for Healing Radiation-Injured Tissues and Organs.Gels (Basel, Switzerland) · 2026Review
- Harnessing plant-derived extracellular vesicles in advanced biomaterials: from structural scaffolds to responsive systems for next-generation wound therapeutics.Burns & trauma · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radiation-induced wounds (RIWs), frequently resulting from radiotherapy, adversely affect clinical outcomes and patient care due to excessive reactive oxygen species (ROS) production, persistent inflammation, and ensuing cellular senescence. This study presents an innovative multifunctional dual-network hydrogel that integrates P1R16, a supramolecular parathyroid hormone-related peptide, into a matrix composed of quaternized chitosan (QCS), oxidized hyaluronic acid (OHA), and paramylon (PM). The hydrogel was designed to address key challenges in RIWs management, including bacterial infection, oxidative stress, cellular senescence, vascularization and tissue regeneration. Its antibacterial properties stem from QCS and PM, while the Schiff-base reaction and ether bonds enhance self-healing and mechanical stability. P1R16 contributes to reducing radiation-induced oxidative damage, inflammation, and senescence, promoting cell viability and facilitating wound healing. A rat model with RIWs demonstrated that QOP@P1R16 effectively accelerates skin regeneration via antibacterial, antioxidant, anti-senescence, and angiogenesis mechanisms. These findings suggest that QOP@P1R16 represents a promising therapeutic strategy for RIWs and other radiation-induced tissue injuries.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.